Epipen - Washington Examiner
Subscribe
Subscribe
Home Tags Epipen

Tag: Epipen

Mylan CEO Heather Bresch in her opening statement will attempt to shift focus to access provided to allergy patients. (Andrew Harrer/Bloomberg)
Healthcare

CEO not expected to offer more discounts for EpiPen

Robert King -
0
The EpiPen and Our Unseemly Dynastic Politics
Magazine

The EpiPen and Our Unseemly Dynastic Politics

Geoffrey Norman -
0
The Senate Finance Committee wrote to the Obama administration on Tuesday to examine whether there is enough oversight of the Medicaid Drug Rebate Program, after concerns that Mylan allegedly manipulated the program to avoid having to pay a higher rebate. (Daniel Acker/Bloomberg)
Healthcare

Senators seek probe of EpiPen rebates

Robert King -
0
Over the past nine years, Medicare spending on EpiPens has increased by 1,151 percent. (Daniel Acker/Bloomberg)
Healthcare

Medicare spending on EpiPens rose past 1,000 percent

Robert King -
0
Mylan acquired the patent for EpiPen in 2007, becoming the sole seller and marketer of this life-saving medication. (Daniel Acker/Bloomberg)
Healthcare

Washington’s monopoly policy

Deane Waldman -
0
Martin Shkreli tweeted his demand on the same day the House Oversight and Government Reform Committee announced a Sept. 21 hearing to scrutinize the price increase of allergy treatment EpiPens. (AP Photo)
Healthcare

Pharma’s Shkreli wants immunity to testify to Congress

Robert King -
0
GAO finds that 300 generic drugs had at least one price hike of 100 percent or more since 2010. (AP Photo/Matt Rourke)
Healthcare

Senators lament spikes in generic drugs

Robert King -
0
Agency has approved three competitors, but doesn't regulate prices, official says. (AP Photo/Jose Luis Magana)
Healthcare

FDA defends itself from EpiPen critics

Robert King -
0
The House Oversight Committee's Sept. 21 hearing will include testimony from Mylan CEO Heather Bresch on the high price tag of $600 for EpiPens. (iStock photo)
Healthcare

House panel to hold hearing over EpiPen price hikes

Robert King -
0
Sen. Chuck Grassley blasted Mylan for insufficient answers to a series of questions he gave the drug maker about the EpiPen price hike. (AP Photo/J. Scott Applewhite)
Healthcare

Do better, Grassley tells EpiPen maker

Robert King -
0
1...345Page 4 of 5
Do Not Sell or Share My Personal Information

NEWS

POLICY

COMMENTARY

RESTORING AMERICA

  • © Copyright 2026. Washington Examiner. All Rights Reserved.